Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 12,7x - 14,1x | 13,4x |
| Selected Fwd EBITDA Multiple | 9,7x - 10,7x | 10,2x |
| Fair Value | ₩38.089 - ₩41.757 | ₩39.923 |
| Upside | -0,8% - 8,7% | 4,0% |
| Benchmarks | Ticker | Full Ticker |
| Philoptics Co., Ltd. | A161580 | KOSDAQ:A161580 |
| Exicon Co., Ltd. | A092870 | KOSDAQ:A092870 |
| Keeps Biopharma Inc. | A256940 | KOSDAQ:A256940 |
| LB Semicon Inc. | A061970 | KOSDAQ:A061970 |
| Tokai Carbon Korea Co., Ltd. | A064760 | KOSDAQ:A064760 |
| Duk San Neolux Co.,Ltd | A213420 | KOSDAQ:A213420 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| A161580 | A092870 | A256940 | A061970 | A064760 | A213420 | ||
| KOSDAQ:A161580 | KOSDAQ:A092870 | KOSDAQ:A256940 | KOSDAQ:A061970 | KOSDAQ:A064760 | KOSDAQ:A213420 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | NM- | NM- | NM- | -5.8% | 7.2% | NM- | |
| 3Y CAGR | NM- | NM- | NM- | -13.7% | -6.2% | 2.9% | |
| Latest Twelve Months | 30.8% | -444.9% | 95.6% | -7.5% | 17.2% | 49.9% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 2.6% | 1.9% | -47.2% | 23.2% | 40.0% | 28.2% | |
| Prior Fiscal Year | 5.3% | 4.6% | 4.9% | 20.1% | 36.1% | 25.5% | |
| Latest Fiscal Year | 5.1% | -41.7% | 6.9% | 17.2% | 34.8% | 29.4% | |
| Latest Twelve Months | 5.1% | -41.7% | 6.9% | 17.2% | 34.8% | 29.4% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.93x | 1.59x | 2.77x | 1.37x | 2.70x | 3.33x | |
| EV / LTM EBITDA | 38.2x | -3.8x | 40.2x | 8.0x | 7.8x | 11.3x | |
| EV / LTM EBIT | 57.2x | -3.2x | 56.8x | -32.9x | 9.2x | 13.5x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -3.8x | 8.0x | 40.2x | ||||
| Historical EV / LTM EBITDA | 11.3x | 14.6x | 23.9x | ||||
| Selected EV / LTM EBITDA | 12.7x | 13.4x | 14.1x | ||||
| (x) LTM EBITDA | 62,460 | 62,460 | 62,460 | ||||
| (=) Implied Enterprise Value | 794,330 | 836,137 | 877,944 | ||||
| (-) Non-shareholder Claims * | 79,601 | 79,601 | 79,601 | ||||
| (=) Equity Value | 873,931 | 915,737 | 957,544 | ||||
| (/) Shares Outstanding | 24.6 | 24.6 | 24.6 | ||||
| Implied Value Range | 35,579.27 | 37,281.30 | 38,983.33 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 35,579.27 | 37,281.30 | 38,983.33 | 38,400.00 | |||
| Upside / (Downside) | -7.3% | -2.9% | 1.5% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A161580 | A092870 | A256940 | A061970 | A064760 | A213420 | |
| Enterprise Value | 793,502 | 50,276 | 353,765 | 614,708 | 745,753 | 863,615 | |
| (+) Cash & Short Term Investments | 88,704 | 39,338 | 22,988 | 77,278 | 285,333 | 71,262 | |
| (+) Investments & Other | 8,430 | 52,162 | 15,110 | 3,729 | (0) | 31,282 | |
| (-) Debt | (66,408) | (7,374) | (55,737) | (387,515) | (649) | (22,849) | |
| (-) Other Liabilities | (83,875) | 0 | (13,087) | (116,236) | 0 | (96) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 740,353 | 134,401 | 323,039 | 191,964 | 1,030,437 | 943,216 | |
| (/) Shares Outstanding | 22.9 | 12.5 | 18.7 | 58.1 | 11.5 | 24.6 | |
| Implied Stock Price | 32,350.00 | 10,750.00 | 17,230.00 | 3,305.00 | 89,800.00 | 38,400.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 32,350.00 | 10,750.00 | 17,230.00 | 3,305.00 | 89,800.00 | 38,400.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |